UNDER THE AUSPICES OF
2nd RIMOGNew and Emerging Therapeutic Options
in Geriatric Oncology
Florence, June 30 - July 1, 2016 Aula Magna NIC - AOUC Careggi
Honorary President: Guido FranciniPresidents: Enrico Mini and Silverio Tomao
Faculty
UNRESTRICTED GRANT BY
Honorary President: Guido FranciniPresidents: Enrico Mini and Silverio Tomao
Meeting VenueAula Magna NIC - AOUC Careggi - Largo Brambilla, 3 - Florence, Italy
General Informationwww.rimog.net
Meeting Secretariat and CME Provider
MI&T Srl - Viale Carducci, 50 - 40125 Bologna Tel. 051 220427 - 335 5918811 - [email protected] - www.mitcongressi.it
CME We required credits CME for the following professionals: Oncologist, Radiotherapist Geriatrician, Surgeon, Biologist, Pathologist and Geneticist.Subscription is free after registration online from the website www.mitcongressi.it section: 2nd RIMOG New and Emerging Therapeutic Options in Geriatric Oncology
SILVER
PLATINUM
Gianni Amunni
Ludovico Balducci
Jonathan A. Ledermann
Fortunato Ciardiello
Scientific CommitteeStuart M. Lichtman
Teresita Mazzei
Carlo Croce
Jean-Pierre Droz
Daniel J. Sargent
Adriano Tocchi
Celestia S. Higano
Joleen M. Hubbard
Scientific CoordinatorsVincenzo Bianco Edoardo Francini Federica Tomao
INTERNATIONALJ.M. Broto Seville (Spain)C. Croce Columbus (USA)J.P. Droz Lyon (France)J.P. Dutcher New York (USA)K. Fizazi Paris (France)R.J. Gralla New York (USA)V. Grünwald Hannover (Germany)C.S. Higano Seattle (USA)J.M. Hubbard Rochester (USA)M.H. Hussain Ann Arbor (USA)F. Joly Caen (France)E. Jonasch Houston (USA)
P.W. Kantoff New York (USA)J.A. Ledermann London (UK)S.M. Lichtman New York (USA)S. Loibl Neu-Isenburg (Germany)S.G. Mohile Rochester (USA)T.S.K. Mok Hong Kong (China)E.A. Perez Rochester (USA)M. Reck Hamburg (Germany)M.T. Seymour London (UK)F.A. Shepherd Toronto (Canada)C. Twelves Leeds (UK)
NATIONAL M. Aglietta TorinoA. Antonuzzo PisaP. Benedetti Panici RomaC. Bengala GrossetoF. Boccardo GenovaS. Bracarda ArezzoF. Cappuzzo RavennaP. Casali MilanoF. Ciardiello NapoliF. Cognetti RomaA.P. Dei Tos Treviso F. Di Costanzo FirenzeG.E. Grignani TorinoA. Lapini FirenzeL. Livi Firenze
M. Mannocci FirenzeP. Marchetti RomaE. Mini FirenzeL. Muzii RomaI. Petrini PisaM. S. Pino FirenzeF. Puglisi UdineV. Quagliuolo MilanoM. R. Raspollini FirenzeA. Riccardi PaviaD. Santini RomaG. Scambia RomaS. Tomao RomaG. Tortora VeronaB. Vincenzi Roma
BRONZE
GOLD
June 30, 2016
July 1, 2016
08:00 Registration
08:30 Opening - G. Francini
08:40 Welcome from Tuscany’s Health Commissioner - S. Saccardi
08:50 Welcome from ITT - G. Amunni
SESSION I MANAGEMENT OF THE ELDERLY WITH CANCERCo-chairs: M. Aglietta, S.M. Lichtman
09:00 The scope of palliative care - S.M. Lichtman
09:20 Developments in the prevention and management of CINV - R.J. Gralla
09:40 Quality of life and pain - J.P. Droz
10:00 Panel discussion - A. Antonuzzo, M. Mannocci, M.S. Pino
10:30 Coffee break
SESSION II BREAST CANCERCo-chairs: C. Croce, E.A. Perez
11:00 Do we need special trials? - C. Twelves
11:20 Role of immunotherapy - E.A. Perez
11:40 Neoadjuvant and postneoadjuvant approaches - S. Loibl
12:00 Panel discussion - P. Marchetti, F. Puglisi, A. Riccardi
SESSION III LUNG CANCERCo-chairs: F. Ciardiello, F.A. Shepherd
12:30 SCLC: updates and state of the art - F.A. Shepherd
12:50 NSCLC: Treatment of EGFR mutation and ALK positive patients - M. Reck
13:10 A new perspective: T-790M inhibition - T.S.K. Mok
13:30 Panel discussion (Role of immunotherapy) - F. Cappuzzo, F. Cognetti, I. Petrini
14:00 Lunch
SESSION IV OVARIAN CANCERCo-chairs: P. Benedetti Panici, J. Ledermann
15:00 Primary surgery or neoadjuvant chemotherapy? - G. Scambia
15:20 What are the optimal medical treatments? - F. Joly
15:40 Panel discussion - L. Muzii, S. Tomao
SESSION V COLORECTAL CANCERCo-chairs: J.M. Hubbard, S.G. Mohile
16:00 Adjuvant therapy - J.M. Hubbard
16:20 Treatment of patients with metastatic disease - M.T. Seymour
16:40 Incorporating the geriatric assessment into the management of older patients - S.G. Mohile
17:00 Panel discussion - F. Di Costanzo, E. Mini, G. Tortora
SESSION VI PROSTATE CANCERCo-chairs: C.S. Higano, P.W. Kantoff
08:30 Update on treatment options for metastatic disease - M.H. Hussain
08:50 Mechanisms of resistance to treatment - P.W. Kantoff
09:10 Personalizing treatments: what is the status? - K. Fizazi
09:30 Panel discussion - F. Boccardo, A. Lapini, M.R. Raspollini
SESSION VII KIDNEY CANCERCo-chairs: J.P. Dutcher, E. Jonasch
09:50 Treatment of RCC - new tools on the horizon - V. Grünwald
10:10 Panel discussion - C. Bengala, S. Bracarda, D. Santini
10:40 Coffee break
SESSION VIII SOFT TISSUE SARCOMACo-chairs: P. Casali, V. Quagliuolo
11:00 Medical treatment in elderly patients - J.M. Broto
11:20 Beyond chemotherapy in elderly patients - L. Livi
11:40 Panel discussion - A.P. Dei Tos, G.E. Grignani, B. Vincenzi
HIGHLIGHTS AND CONCLUSIONSCo-chairs: P.W. Kantoff, E.A. Perez
12:10 Breast cancer - C. Twelves
12:20 Lung cancer - F. Ciardiello
12:30 Ovarian cancer - J.A. Ledermann
12:40 Colorectal cancer - J.M. Hubbard
12:50 Prostate cancer - C.S. Higano
13:00 Kidney cancer - J.P. Dutcher
13:10 Soft Tissue Sarcoma - P. Casali
13:20 Management of the elderly with cancer - S.M. Lichtman
13:30 Closing - G. Francini
13:40 Lunch